W065--South Texas VA Geenius HIV Lease and Reagents
See the original posting, the buyer’s contact details, and thousands more contracts like this one
Free account. Already have one? Log in
Description
Sources Sought Notice This notice is for planning purposes only and shall not be considered an invitation for bid, request for quotation, request for proposal, or as an obligation of the government to acquire any products or services. Responses to this notice will be used for informational purposes only. No entitlement to payment of direct or indirect costs from the government will arise as a result from a response to this announcement. No contract will be awarded from this notice. The information requested in this notice will be used to determine if there are sufficient socioeconomic small business concerns that are capable of performing the work described for the requirement. The South Texas Veterans Health Care System (STVHCS) has a need for a Cost per Reagent Rental agreement for the Geenius Automated HIV ½ System with single-use immunochromatographic assay for the confirmation and differentiation of individual antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV-1 and HIV-2) in serum, or plasma samples, lithium heparin, sodium citrate, and CPD) from blood donor that will include preventative service, maintenance and to be housed in the Molecular Laboratory of Pathology & Laboratory Medicine Service at Audie L. Murphy VA Hospital. The Geenius System and its associated HIV1/2 supplemental assay is the confirmatory test done on all patients whose initial screening test is positive for HIV. Currently this confirmation is done in-house. This test confirms HIV infection for positive screens and differentiates HIV1 from HIV2, since the two types have markedly different clinical courses and treatment implications. STVHCS serves a patient population with a high prevalence of HIV, and accurate, rapid diagnosis is key to ensuring proper care and limiting spread of the infection within the community. Sending this test to a reference lab would be at a higher cost, and delay results by several days. This would likely result in newly diagnosed patients being lost to …